US2.AI

AI Echocardiography Reporting Software, FDA-Cleared

Singapore, Singapore · Founded 2017 · $15.0M raised

Headquarters
Singapore
Founded
2017
Business Model
B2B
Website
us2.ai
Total Funding
$15.0M
Last Round
$15.0M Series AApr 2022
Rounds
2

About

Us2.ai was founded in Singapore in 2017 as eko.ai by James Hare, Dr. Carolyn Lam, and Dr. Yoran Hummel, with a mission to democratize expert-level cardiac diagnostics through AI. The company earned FDA 510(k) clearance in 2021 for its first fully automated echo decision-support tool and rebranded to Us2.ai, followed by CE Mark clearance and a Series A round led by IHH Healthcare in 2022. Its AI-assisted echocardiography analysis has since been validated in The Lancet Digital Health and studied in trials including the OPERA study at ESC and the AI-ECHO RCT at AHA.

Summary

US2.AI is an Artificial Intelligence company based in Singapore, Singapore, founded in 2017. It has raised $15.0M in total across 2 rounds, most recently a $15.0M Series A round in Apr 2022. Investors include Peak XV Partners, EDBI and Partech.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2022
$15.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

US2.AI on Indexed.vc
<a href="https://indexed.vc/companies/us2-ai"><img src="https://indexed.vc/api/badge/company/us2-ai" alt="US2.AI on Indexed.vc" width="260" height="76" /></a>